You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches

ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

Pulmonology

17 min

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Pulmonology

29 min

expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Gastroenterology

5 min

Infographic

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

Podcast

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Dermatology

42 min

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Dermatology

5 min

Infographic

The Burden of AD: More Than Skin Deep

The Benefits of Early Intervention in AD: More Than Skin Deep

Dermatology

82 min

expert video

The Benefits of Early Intervention in AD: More Than Skin Deep

Learning hub

EoE

Check the new ADVENT EoE Learning Hub page to learn more about the pathophysiology, disease burden and management of EoE featuring educational resources.

Recently added

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Gastroenterology

8 min

interactivity

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Dermatology

3 min

expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Epidemiology and Pathophysiology of AD in Children

Dermatology

2 min

expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Dermatology

2 min

expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Dermatology

10 min

expert video

Unmet Needs for Bullous Pemphigoid (BP): Limitations of Diagnosis and Conventional Therapies

Dermatology

15 min

expert video

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

Popular in United States

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

Pulmonology

5 min

interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?

Pulmonology

2 min

expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD

Pulmonology

2 min

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand event highlights

Join Profs. Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller for an educational symposium exploring the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

2 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Highlights from the ADVENT educational symposium at EADV 2024 where Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

Join experts Dedee Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational symposium on the clinical presentation, disease burden, diagnosis and pathophysiology of BP.

6 assets

Bullous Pemphigoid: Exploring New Frontiers

Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).

4 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Professors Klaus Rabe, Paola Rogliani, and Dr. Stephanie Christenson explore the complexity of inflammatory pathways and phenotypes in COPD. They provide insights into the genetic association of IL-33 with COPD, and discuss preclinical findings.

3 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz and Mona Bafadhel for an educational symposium exploring the role of type 2 cytokines in COPD and delve into the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden.

3 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

3 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

2 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

8 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Drs Sarina Elmariah and Mona Shahriari discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncover how clinical signs and itch in these diseases are impacted by type 2 inflammation.

11 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

The following materials review the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient, improving clinical management and reducing long-term patient burden.

1 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of biomarker assessments in guiding management strategies of recognizing the heterogeneity of COPD.

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

Join Drs. James Del Rosso and Raj Chovatiya for an education program to explore the impact, contribution, and diagnosis of type 2 inflammation on atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

1 assets

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

Explore all educational resources

Upcoming events

7March2025

Congress

ADVENT in Orlando, 2025

Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join global experts for an educational symposium on March 8th that will uncover the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP and explore questions driving current research in each disease.

Future events

7March2025

Congress

ADVENT in Orlando, 2025

Sign up to ADVENT

ADVENT is a medical education program dedicated to Type 2 Inflammation across multiple therapeutic areas. Registering for ADVENT is free and unlocks unlimited access to exclusive features and a wealth of content relevant to the practice of Dermatology, Pulmonology, Rhinology, and Gastroenterology. Sign up now!

Hear from ADVENT experts

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

On demand event highlights

2 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

6 assets

Bullous Pemphigoid: Exploring New Frontiers

Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).

4 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

3 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

3 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

3 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

2 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

8 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

11 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

1 assets

Anosmia Awareness Day 2024

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

1 assets

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

Explore all educational resources

Welcome to ADVENT!

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Burden of AD: More Than Skin Deep

The Benefits of Early Intervention in AD: More Than Skin Deep

Recently added

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Epidemiology and Pathophysiology of AD in Children

Considerations for Disease Modification in AD

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid

Etiology and Diagnosis of Bullous Pemphigoid

The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)

Scratching the Surface: Understanding Itch in Prurigo Nodularis

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

UEGW 2024 | Something to Chew On: Exploring the Management of EoE

Understanding Disease Mechanisms

Stepping Into Hand and Foot Dermatitis

Unveiling Atopic Dermatitis

ADVENT On Air | Expert Discussions in Dermatology

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Pathophysiology of Blister Formation in Bullous Pemphigoid

Unmet Needs for Bullous Pemphigoid (BP): Limitations of Diagnosis and Conventional Therapies

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

Popular in United States

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand event highlights

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Bullous Pemphigoid: Exploring New Frontiers

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Lung Function White Board Videos

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Benefits of Early Intervention In AD: More Than Skin Deep

Anosmia Awareness Day 2024

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Upcoming events

ADVENT in Orlando, 2025

Future events

ADVENT in Orlando, 2025

Sign up to ADVENT

Hear from ADVENT experts

Meet our experts

Katrina Abuabara

Seema Aceves

Alvar Agusti

Paolo Amerio

Peter Arkwright

April Armstrong

Ulrike von Arnim

Dhandapani Ashok

Leonard Bacharier

Claus Bachert

Vibeke Backer

Mona Bafadhel

Christine Bangert

Igor Barjaktarevic

Eulàlia Baselga

Eric Bateman

Lisa Beck

Anna Belloni Fortina

Thomas Bieber

Tilo Biedermann

Recommended for you